MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05034naaaa2201225uu 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
https://directory.doabooks.org/handle/20.500.12854/69097 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20220714181505.0 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
books978-3-03943-091-8 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783039430901 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783039430918 |
| 024 7# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.3390/books978-3-03943-091-8 |
| Terms of availability |
doi |
| 041 0# - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
English |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
dc |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
M |
| Source |
bicssc |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Müller, Rüdiger |
| Relator code |
edt |
| 9 (RLIN) |
1599056 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Rheumatoid Arthritis Therapy Reappraisal : Strategies, Opportunities and Challenges |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Basel, Switzerland |
| Name of publisher, distributor, etc |
MDPI - Multidisciplinary Digital Publishing Institute |
| Date of publication, distribution, etc |
2020 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 electronic resource (260 p.) |
| 506 0# - RESTRICTIONS ON ACCESS NOTE |
|---|
| Terms governing access |
Open Access |
| Source of term |
star |
| Standardized terminology for access restriction |
Unrestricted online access |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Rheumatoid Arthritis (RA) is a chronic inflammatory disease leading to joint inflammation and destruction. Treatment of RA includes the use of conventional (cs), biologic (b) disease-modifying anti-rheumatic drugs (DMARDs), and oral or intraarticular (IA) glucocorticoids (GCs). All different classes of drugs have shown to halt disease progression in clinical studies. In real life, a physician has more options than just adding or switching to a new ts/bDMARD if any kind of DMARDs has failed. They can modify or optimize the therapy with concomitant csDMARDs, and oral or IA-GC can be added to the treatment regimen. The EULAR states that therapeutic adjustment including the "optimization of csDMARDs dose or route of administration or intra-articular injections of GCs" is recommended. Thus, a new therapeutic agent can be embedded in a whole strategy with parallel optimization of the csDMARD and GC treatment. The idea of treating to target (T2T) for the treatment of RA patients has been around since the late 1990s. Many clinical studies (Ticora, BsSt, Camera) have demonstrated the superiority of a T2T approach. When I talk to physicians, I understand that most of them only rarely inject joints with GC. Therefore, I would like to create an issue on the T2T approach in reality including primary data, reviews, and real-life data demonstrating the general opinion and execution of T2T in treating RA. |
| 540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE |
|---|
| Terms governing use and reproduction |
Creative Commons |
| -- |
https://creativecommons.org/licenses/by/4.0/ |
| -- |
cc |
| -- |
https://creativecommons.org/licenses/by/4.0/ |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
English |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Medicine |
| Source of heading or term |
bicssc |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
rheumatoid arthritis |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
sleep |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
sleep disorders |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
pain |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
osteoporosis |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
fracture |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
fracture risk assessment tool |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
treat-to-target |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
certolizumab pegol |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
csDMARDs |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
glucocorticoids |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
intra-articular injections |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
DAS 28 |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
ACR response |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
HAQ-DI |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
TNFα |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
golimumab |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
efficacy |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
tolerability |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
immunogenicity |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
methotrexate |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
posology |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
titration |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
oral route |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
subcutaneous route |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
bioavailability |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
effectiveness |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
periodontitis |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
periodontal disease |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
anti-citrullinated protein autoantibodies |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
rheumatoid factor |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
smoking |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
medication |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Porphyromonas gingivalis |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Rheumatoid arthritis |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
matrix metalloproteinase 3 |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
infliximab |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
pharmacogenomics |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
anti-TNF |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
personalized medicine |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
baricitinib |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
disease-modifying antirheumatic drugs |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
pain perception |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
outcomes research |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
patient perspective |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Rheumatoid Arthritis |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
therapy |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
DMARD |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
MTX |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Tumor Necrosis Factor-Alpha Inhibitors |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
ankylosing spondylitis |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
biosimilar |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
switching |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
synovial fibroblasts |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
cytokine |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
osteoclast |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
herbal medicine |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
methylation |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
next-generation sequencing |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
recovery of function |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
fatigue |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
productivity |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
tofacitinib |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
oral |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Th1.17 |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
IL-17A |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
IFN-γ, CD73 |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
adenosine |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
psoriatic arthritis |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
regulation |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
pseudoerosions |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
hand |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
foot |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
ultrasonography |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
radiography |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
computed tomography |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
magnetic resonance imaging |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
n/a |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Müller, Rüdiger |
| Relator code |
oth |
| 9 (RLIN) |
1599056 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Host name |
www.oapen.org |
| Uniform Resource Identifier |
<a href="https://mdpi.com/books/pdfview/book/2866">https://mdpi.com/books/pdfview/book/2866</a> |
| -- |
0 |
| Public note |
DOAB: download the publication |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Host name |
www.oapen.org |
| Uniform Resource Identifier |
<a href="https://directory.doabooks.org/handle/20.500.12854/69097">https://directory.doabooks.org/handle/20.500.12854/69097</a> |
| -- |
0 |
| Public note |
DOAB: description of the publication |
